You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thymus Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thymoma, Thymus Tumors Trial run by the NCI (Sunitinib)

Active, not recruiting
Has Results
  • Thymoma
  • Thymus Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 17, 2022

NSCLC, Mesothelioma, Bladder Cancer Trial in Augusta (Bosutinib, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Jun 10, 2022

Thyroid Cancer Trial in Hangzhou (Resection based on "thymus-vascular-inferior parathyroid" complex)

Not yet recruiting
  • Thyroid Cancer
  • Resection based on "thymus-vascular-inferior parathyroid" complex
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital Zhejiang University School of Medicin
Feb 24, 2023

Thymic Carcinoma Trial in Shanghai (Envolizumab combined with radiotherapy)

Recruiting
  • Thymic Carcinoma
  • Envolizumab combined with radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 3, 2023

Molecular Analysis of Thoracic Malignancies

Enrolling by invitation
  • Thymus Cancer
  • +5 more
    • Stanford, California
      Stanford University School of Medicine
    Jun 8, 2021

    Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Bourdeaux, France
    • +24 more
    Jun 23, 2023

    Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer Trial run by the NCI (PT-112)

    Recruiting
    • Thymic Epithelial Tumor
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Molecular Analysis and Treatment Options of Thymic Malignancies

    Recruiting
    • Thymic Epithelial Tumor
    • +2 more
    • Shanghai, Shanghai, China
      Xiaomin Niu
    Dec 28, 2022

    Rapid Autopsy and Procurement of Cancer Tissue

    Recruiting
    • Thymus Tumors
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 20, 2022

      Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

      Recruiting
      • Adenocarcinoma
      • +75 more
      • Biomarker Testing (L)
      • +2 more
      • Idaho Falls, Idaho
      • +1 more
      Oct 18, 2022

      Thymoma, Thymic Cancer Trial in Houston (Pembrolizumab)

      Recruiting
      • Stage III Thymoma AJCC v8
      • +6 more
      • Pembrolizumab
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 11, 2022

      Esophageal Tumors, Lung Tumors, Mesothelioma Trial run by the NCI (Mithramycin)

      Terminated
      Has Results
      • Esophageal Neoplasms
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Mar 10, 2022

      Recurrent Malignant Thymoma, Thymoma Trial in Houston (Diaphragm Fluoroscopy, Magnetic Resonance Imaging)

      Active, not recruiting
      • Recurrent Malignant Thymoma
      • Thymoma
      • Diaphragm Fluoroscopy
      • Magnetic Resonance Imaging
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 22, 2022

      Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

      Completed
      • Pancreas Cancer
      • +6 more
      • Rozzano, Milan, Italy
        Istituto Clinico Humanitas
      Sep 9, 2022

      Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2

      Recruiting
      • Thyroid Cancer, Medullary
      • +3 more
      • Basel, Switzerland
        University Hospital Basel, Clinic for radiology and nuclear medi
      May 23, 2022

      YY-20394 in Patients With Relapsed/Refractory Thymic Cancer

      Not yet recruiting
      • Effectiveness，Safety，Thymic Cancer
      • (no location specified)
      Jul 20, 2021

      Cardiac MRI Biomarker Testing (GCC 1618)

      Recruiting
      • Breast Cancer
      • +4 more
      • Complete Cardiac Magnetic Resonance Imaging (MRI)
      • Baltimore, Maryland
        Ummc Msgccc
      Aug 16, 2021

      Neuroendocrine Tumors, Carcinoma, Small Cell Lung, Neuroendocrine Carcinoma Trial in United Kingdom, United States (PEN-221)

      Completed
      Has Results
      • Neuroendocrine Tumors
      • +2 more
      • Fort Myers, Florida
      • +12 more
      Nov 16, 2021

      Thymoma and Thymic Carcinoma Trial in Guangzhou (Thymosin a1, hypofractionated radiotherapy, concurrent chemoradiotherapy)

      Active, not recruiting
      • Thymoma and Thymic Carcinoma
      • Thymosin a1
      • +2 more
      • Guangzhou, Guangdong, China
        Sun yat-sen University Cancer Center
      Nov 27, 2021

      Thymoma, Thymic Carcinoma, Clinical Masaoka Stage II to IVA Trial in United States (Cetuximab, Cisplatin, Doxorubicin &

      Active, not recruiting
      • Thymoma
      • +2 more
      • Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
      • Duarte, California
      • +7 more
      May 27, 2022

      Thymoma Malignant Recurrent Trial in France (Radiotherapy, Surveillance after resection)

      Recruiting
      • Thymoma Malignant Recurrent
      • Radiotherapy
      • Surveillance after resection
      • Angers, France
      • +17 more
      Aug 8, 2022

      Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

      Recruiting
      • Thyroid
      • +18 more
      • New Haven, Connecticut
      • +6 more
      Apr 8, 2022

      Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

      Recruiting
      • Pancreatic Cancer
      • +49 more
        • Colorado Springs, Colorado
        • +80 more
        Feb 22, 2022

        Advanced Digestive System Neuroendocrine Tumor, Duodenal Neuroendocrine Tumor G1, Functional Pancreatic Neuroendocrine Tumor

        Completed
        Has Results
        • Advanced Digestive System Neuroendocrine Neoplasm
        • +7 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 8, 2020

        Type B3 Thymoma, Thymic Carcinoma Trial in Milan (Sunitinib)

        Recruiting
        • Type B3 Thymoma
        • Thymic Carcinoma
        • Milan, Italy
          National Cancer Institute
        Jun 8, 2021